Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 303.59M | 371.42M | 490.17M | 650.25M | 681.74M |
| Total Depreciation and Amortization | 231.43M | 234.16M | 233.00M | 224.67M | 222.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.34M | 24.77M | 56.71M | 60.44M | 10.53M |
| Change in Net Operating Assets | -243.44M | -168.33M | -137.11M | -209.47M | -232.47M |
| Cash from Operations | 338.92M | 462.01M | 642.77M | 725.90M | 681.82M |
| Capital Expenditure | -186.22M | -220.93M | -264.86M | -303.78M | -313.71M |
| Sale of Property, Plant, and Equipment | 12.36M | 6.86M | 3.46M | 1.63M | 2.83M |
| Cash Acquisitions | -36.78M | -36.78M | -34.45M | -19.12M | -19.12M |
| Divestitures | 52.90K | 52.90K | -- | -- | -- |
| Other Investing Activities | -109.09M | -222.94M | -442.75M | -281.50M | -221.85M |
| Cash from Investing | -319.66M | -473.74M | -738.60M | -602.77M | -551.85M |
| Total Debt Issued | 17.58B | 20.19B | 20.26B | 6.75B | -391.00M |
| Total Debt Repaid | -6.26B | -6.76B | -1.26B | -1.11B | -1.12B |
| Issuance of Common Stock | 425.00M | 449.00M | 397.00M | 329.00M | 324.00M |
| Repurchase of Common Stock | -- | -- | -- | -1.39B | -1.39B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -69.72M | -76.27M | -76.27M | -76.27M | -76.27M |
| Other Financing Activities | -4.96B | -4.84B | -4.44B | -4.05B | -4.07B |
| Cash from Financing | 9.74M | 27.96M | 89.21M | -72.87M | -153.19M |
| Foreign Exchange rate Adjustments | 10.01M | 12.27M | 13.93M | 11.04M | 6.96M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.01M | 28.51M | 7.31M | 61.29M | -16.26M |